Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
SLAM DRILLS MORE COPPER MINERALIZATION AT GOODWIN (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aurora Cannabis Inc T.ACB

Alternate Symbol(s):  ACB | T.ACB.WS.U

Healthcare Cannabis
Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company's principal business lines are focused on the production, distribution, and sale of cannabis related products in Canada and internationally. The Company’s segments include Canadian Cannabis, European Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being and Greybeard, as well as CBD brands, Reliva and KG7. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol and CraftPlant. Its cannabis products are primarily cultivated and manufactured in the facilities in Edmonton, Alberta; Bradford Ontario; Pemberton, British Columbia, and Odense, Denmark. The Company is focused on offering its cannabis products to global medical cannabis market, recreational cannabis market and global hemp-derived cannabidiol (CBD) markets.


TSX:ACB - Post by User

Aurora Cannabis Inc
Bullboard Posts
User Avatar Image
(0)
•••
Comment by JohnnyNoBrakeson Dec 19, 2018 3:21pm
71 Views
Post# 29136529

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:The shares offered from previous deals haven’t gone through

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:The shares offered from previous deals haven’t gone throughAurora Cannabis Inc. (ACB) is projected to climb by -100 percent over the next 12 months, according to price target estimates compiled by finviz. Meanwhile, they have set a $17-month high price target. This represents a whopping 207.41 percent increase from where shares are trading today. The 12-month median price target assigned by the analysts stands at $13, which represents a return potential of 135.08 percent when compared to the closing price of the stock of $5.53 on Tuesday, December 18. The lowest price target for the stock is $8.5 — slightly more than 53.71 percent from ACB’s current share price.
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities